Healthcare Services

AI-Powered Diagnostics Advancing Growth in Tumor Profiling Market

April 28, 2026April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Tumor Profiling Market Progress Between 2026 And 2030?

The tumor profiling market has seen swift growth in recent years. Its value is anticipated to rise from $11.18 billion in 2025 to $12.31 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.1%. This expansion in prior periods can be attributed to several factors including an increase in cancer incidence rates, the proliferation of molecular diagnostics laboratories, enhanced application of targeted cancer therapies, continuous advancements in sequencing technologies, and a boost in oncology research funding.

The tumor profiling market is projected to undergo significant expansion in the coming years. It is forecasted to reach a size of $17.96 billion by 2030, expanding at a compound annual growth rate (CAGR) of 9.9%. This growth throughout the forecast period is driven by factors such as the increasing implementation of precision oncology, the escalating demand for individualized cancer treatments, improvements in bioinformatics platforms, the wider availability of companion diagnostics, and rising investments in translational cancer research. Prominent trends for the forecast period include the broader uptake of next-generation sequencing, an increased reliance on multi-omics profiling strategies, the growing incorporation of AI-powered data interpretation, the expansion of personalized oncology applications, and a reinforced emphasis on biomarker discovery.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp

Which Important Drivers Are Guiding The Tumor Profiling Market Growth?

The expanding requirement for personalized medicine is projected to propel the development of the tumor profiling market moving ahead. Personalized medicine denotes a strategy that customizes medical treatments according to the unique traits of each patient. This upsurge stems from patients’ pursuit of more accurate therapies that deliver enhanced results and fewer adverse reactions compared to conventional treatments. Tumor profiling supports personalized medicine by detecting particular genetic mutations and biomarkers within a patient’s tumor, thus facilitating targeted therapies and minimizing side effects. For instance, in February 2024, a report from the Personalized Medicine Coalition, a US-based organization committed to advancing personalized medicine, indicated that personalized medicines constituted over one-third of all new drug approvals in 2023, marking the fourth consecutive year of this pattern. Consequently, the increasing need for personalized medicine is stimulating expansion in the tumor profiling market.

What Are The Main Segments Within The Tumor Profiling Market Segment Structure?

The tumor profiling market covered in this report is segmented –

1) By Technique: Genomics, Proteomics, Epigenetics, Metabolomics

2) By Technology: Sequencing Techniques, Quantitative Polymerase Chain Reaction (qPCR), Immunohistochemistry, In Situ Hybridization (ISH), Microarray

3) By Application: Personalized Cancer Medicine, Oncological Diagnostics, Research

Subsegments:

1) By Genomics: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarrays, Sanger sequencing

2) By Proteomics: Mass Spectrometry (MS), Protein Microarrays, Immunohistochemistry (IHC), Western Blotting

3) By Epigenetics: DNA Methylation Analysis, Chromatin Immunoprecipitation Sequencing (ChIP-seq), Histone Modification Profiling, Non-Coding RNA Analysis

4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy, Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), Capillary Electrophoresis-Mass Spectrometry (CE-MS)

What Trends Are Influencing The Evolution Of The Tumor Profiling Market?

Leading firms in the tumor profiling sector are concentrating on creating sophisticated solutions, including AI-driven diagnostic tools, aimed at improving precision and speed in cancer therapy. AI, or artificial intelligence, involves employing sophisticated computational techniques to scrutinize intricate genomic, proteomic, and clinical information, thereby facilitating quicker diagnoses, tailored treatment plans, and improved oversight of disease evolution. As an illustration, in January 2025, Panakeia Technologies LTD, a UK firm focused on AI-powered software for cancer diagnosis and therapy, introduced PANProfiler Colon. This AI-driven software is specifically designed to identify critical molecular biomarkers like microsatellite instability (MSI) and mismatch repair deficiency (dMMR) using H and E-stained images from colon cancer tissue samples. This digital instrument allows for swift and precise molecular profiling of tumors, a crucial capability for diagnosing colorectal cancer, detecting instances of Lynch syndrome, and guiding individualized treatment choices.

Who Are The Companies Participating In The Tumor Profiling Market?

Major companies operating in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., Predictive Oncology Inc.

Get The Full Tumor Profiling Market Report:

https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report

Which Region Leads The Tumor Profiling Market In Overall Market Size?

North America was the largest region in the tumor profiling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Tumor Profiling Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report

Browse Through More Reports Similar to the Global Tumor Profiling Market 2026, By The Business Research Company

Cancer Profiling Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Cancer Diagnostics Market Report

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cancer Biomarker Market Report

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795